Non-Hodgkin Lymphoma Survivors: Secondary Malignancy Risk The number of non-Hodgkin lymphoma (NHL) cases is rising, with an estimated 81,560 new diagnoses in the US in 2021. As survival rates improve, more NHL survivors face potential late effects, including secondary malignancies (SM) linked to treatments like chemotherapy and radiation. This research revisits
Tag: radiation therapy
Renal Transplant Risks With Prostate Cancer
Renal Transplant Risks With Prostate Cancer Overview Renal transplant candidates are recommended to undergo a systematic screening for prostate cancer at the time of listing. It is a growing concern that low-risk prostate cancer diagnosis may lead to reduced access to renal transplant services without any significant oncological benefit. The aim of this
Radiation therapy And VTE Risk
Radiation therapy And VTE Risk Thromboembolic events are often the primary cause of complications in malignancies. They also have a major effect on the morbidity and mortality of cancer patients. Compared to chemotherapy and other kinds of systemic therapies, there’s not enough data about the impact of ionizing radiation on the
Pseudouveitis with pancreatic carcinoma: a case study
Pseudouveitis with pancreatic carcinoma: a case study Overview of the Study This study is a report of a case of a 61- year- old man who presented with progressive deterioration of general condition with unilateral recurrent episodes of pseudouveitis presenting as non- granulomatous panuveitis of the left eye related to a choroidal
incidence of secondary cancers after cirt vs rt
incidence of secondary cancers after cirt vs rt Overview of the Study The risk of secondary cancer after carbon-ion radiotherapy (CIRT) has not been well studied. In this study, the researchers assessed the incidence of secondary cancers in patients who have undergone CIRT for cervical cancer. Aside from CIRT, the researchers also
Sexual Dysfunction in Prostate Cancer Treatments: Survey Results
Study Results: The Effects of Sexual Dysfunction in Prostate Cancer Patients Prostate cancer is the most common cancer in males, with more than 57,000 new cases each year. It accounts for around 26% of all male cancer cases. About one in six individuals with prostate cancer has advanced disease progression. Treatment of
